Share Facebook Twitter LinkedIn Pinterest Email European stocks slip as investors weigh earnings, oil prices and U.S. election risks
Bioventus expects 2026 revenue of $590M-$595M while reaffirming adjusted EPS of $0.75-$0.79 (NASDAQ:BVS)November 3, 2026